OTC Markets OTCQB - Delayed Quote USD

DIAGNOS Inc. (DGNOF)

0.1500
-0.0100
(-6.25%)
At close: June 5 at 8:00:00 PM EDT
Loading Chart for DGNOF
  • Previous Close 0.1600
  • Open 0.1528
  • Bid 0.1480 x 1000000
  • Ask 0.1600 x 1500000
  • Day's Range 0.1528 - 0.1528
  • 52 Week Range 0.1500 - 0.3100
  • Volume 5,000
  • Avg. Volume 41,301
  • Market Cap (intraday) 14.272M
  • Beta (5Y Monthly) -0.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Aug 19, 2025 - Aug 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

www.diagnos.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: DGNOF

View More

Performance Overview: DGNOF

Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

DGNOF
25.00%
S&P/TSX Composite index (^GSPTSE)
7.35%

1-Year Return

DGNOF
34.78%
S&P/TSX Composite index (^GSPTSE)
18.89%

3-Year Return

DGNOF
15.38%
S&P/TSX Composite index (^GSPTSE)
26.95%

5-Year Return

DGNOF
25.00%
S&P/TSX Composite index (^GSPTSE)
66.70%

Compare To: DGNOF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DGNOF

View More

Valuation Measures

Annual
As of 6/6/2025
  • Market Cap

    14.27M

  • Enterprise Value

    14.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    177.21

  • Price/Book (mrq)

    85.05

  • Enterprise Value/Revenue

    186.34

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -111.17%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    103.8k

  • Net Income Avi to Common (ttm)

    -4.29M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.24M

  • Total Debt/Equity (mrq)

    1,317.69%

  • Levered Free Cash Flow (ttm)

    -2.6M

Research Analysis: DGNOF

View More

Company Insights: DGNOF

Research Reports: DGNOF

View More

People Also Watch